The prevalence of sickle cell disease in Africa is the highest in the world. Sub-Saharan Africa accounts for the large majority of babies born with sickle cell disease each year, with the heaviest burden across a belt of West, Central, and East Africa, and Nigeria has more affected births than any other country. The main reason is malaria: carrying one sickle gene protects against severe malaria, so over many generations the gene became common wherever malaria was widespread.
Below, I explain the genetics behind that pattern, what the disease does to the body, and how diagnosis and care work, including the particular challenges in African health systems.
What Is Sickle Cell Disease?
Sickle cell disease (SCD) is an inherited blood disorder in which red blood cells contain an abnormal form of hemoglobin called hemoglobin S (HbS). When oxygen levels fall, HbS molecules stick together into long rigid strands, bending the red cell into a crescent or “sickle” shape.
Sickled cells are stiff and fragile. They block small blood vessels, causing pain and organ damage, and they break down early, living only about 10 to 20 days instead of the normal 120. The result is lifelong hemolytic anemia and episodes of vessel blockage.
The Genetics in Brief
The disease comes from a single change in the HBB gene, which codes for the beta-globin chain of hemoglobin. It is inherited in an autosomal recessive pattern:
- One sickle gene plus one normal gene gives sickle cell trait (HbAS). Carriers are usually healthy.
- Two sickle genes give sickle cell anemia (HbSS), the most common and usually most severe form.
- One sickle gene plus another abnormal gene, such as hemoglobin C or beta-thalassemia, gives other forms of SCD (HbSC, HbS/beta-thalassemia).
When both parents carry the trait, each pregnancy has a 1 in 4 chance of a child with SCD, a 1 in 2 chance of a carrier, and a 1 in 4 chance of a child with neither gene.
Why Is Sickle Cell So Common in Africa?
The answer is a textbook example of natural selection. People with sickle cell trait are substantially protected against severe and fatal Plasmodium falciparum malaria, the deadliest malaria parasite. Infected red cells in carriers tend to sickle and are cleared by the spleen before the parasite can multiply as effectively.
In regions where malaria killed many young children, carriers were more likely to survive to adulthood and have children themselves. This heterozygote advantage kept the sickle gene common, even though inheriting two copies causes serious disease.
A Map That Mirrors Malaria
The distribution of the sickle gene closely overlaps the historical range of falciparum malaria. Carrier rates are highest in equatorial Africa and lower in North Africa and the far south, where malaria was historically less intense. The same protective mutation also arose or spread in parts of the Middle East and India, which have their own distinct gene patterns.
Researchers have identified several African haplotypes, genetic backgrounds on which the mutation is found, named after the regions where they are common: Senegal, Benin, Bantu (Central African Republic), and Cameroon. These backgrounds partly influence how much protective fetal hemoglobin a person makes, which affects disease severity.
| Region | General pattern of sickle gene frequency |
|---|---|
| West Africa (e.g., Nigeria, Ghana) | High; very large number of affected births because of large populations |
| Central Africa (e.g., DR Congo, Cameroon) | High |
| East Africa (e.g., Uganda, Tanzania, Kenya) | Moderate to high, varying by region and altitude |
| North Africa | Lower, with pockets of higher frequency |
| Southern Africa | Generally lower |
Symptoms and Complications
Symptoms usually start in the first year of life, as protective fetal hemoglobin is replaced by adult hemoglobin. Common problems include:
- Vaso-occlusive crises – sudden episodes of severe pain in bones, chest, or abdomen
- Painful swelling of the hands and feet (dactylitis) in infants
- Fatigue and pallor from chronic anemia
- Serious bacterial infections, because the spleen is damaged early in life
- Splenic sequestration, where blood pools suddenly in the spleen
- Stroke, acute chest syndrome, and slowed growth in children
In Africa, these complications interact with malaria, which can trigger crises and severe anemia in people with SCD. Without early diagnosis, infection prevention, and basic care, many children with SCD in low-resource settings do not survive early childhood.
Diagnosis and Newborn Screening
Accurate diagnosis of sickle cell disease relies on identifying the types of hemoglobin in the blood.
- Hemoglobin electrophoresis separates hemoglobin variants in an electric field.
- High-performance liquid chromatography (HPLC) measures each hemoglobin fraction precisely.
- Point-of-care tests – low-cost rapid tests that detect HbS and other variants from a drop of blood, useful where laboratories are scarce.
- Newborn screening identifies affected babies before symptoms, so preventive care can start early.
Several African countries run newborn screening programs, but coverage remains limited in many areas. Expanding screening is one of the most effective ways to reduce early deaths.
Treatment and Management
Standard care focuses on preventing complications and treating crises quickly:
- Penicillin prophylaxis and vaccinations (including pneumococcal vaccines) to prevent serious infections in young children
- Malaria prevention, such as bed nets and preventive antimalarials where recommended
- Folic acid to support red cell production
- Hydroxyurea, which raises fetal hemoglobin and reduces pain crises, acute chest syndrome, and transfusion needs
- Pain management and hydration during crises
- Blood transfusion for severe anemia and stroke prevention
- Transcranial Doppler screening to identify children at high stroke risk
Hematopoietic stem cell transplantation can cure SCD, and gene therapies have been approved in some high-income countries. Both are expensive and specialized, so access in most of Africa is currently very limited. Making hydroxyurea, screening, and basic preventive care widely available is where the greatest gains lie. For more detail on care, see our sickle cell guide.
Key Takeaways
- Sub-Saharan Africa carries the world’s highest burden of sickle cell disease.
- The sickle gene became common because carriers are protected against severe falciparum malaria.
- Two carrier parents have a 1 in 4 chance of an affected child in each pregnancy.
- Newborn screening, infection prevention, malaria control, and hydroxyurea save lives.
- Curative treatments exist but remain out of reach for most African patients.
Frequently Asked Questions
Why does sickle cell trait protect against malaria?
Red cells containing some HbS are a poor environment for the malaria parasite. Infected cells tend to sickle and are removed by the spleen, limiting the parasite’s growth. Trait carriers can still catch malaria, but they are much less likely to develop the severe, life-threatening form.
Is sickle cell disease only found in people of African descent?
No. It is also common in parts of the Middle East, India, and the Mediterranean, and in Caribbean and Latin American populations. Migration has spread it worldwide, so it is seen in every region.
Can two carriers have a healthy child?
Yes. Each pregnancy has a 3 in 4 chance of a child without sickle cell disease, though half of all children will be carriers. Genetic counseling and prenatal testing can help couples understand their options.
Does sickle cell trait cause health problems?
Most carriers live normal, healthy lives. Rarely, problems can occur under extreme conditions such as severe dehydration, very intense exertion, or high altitude. Knowing your trait status is useful for family planning.
